Literature DB >> 20733951

Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

Peggy S Sullivan, Jessica B Chan, Mary R Levin, Jianyu Rao.   

Abstract

Urine cytology coupled with cystoscopic examination has been and remains the standard in the initial evaluation of lower urinary tract lesions to rule out bladder cancer. However, cystoscopy is invasive and may miss some flat lesions, whereas cytology has low sensitivity in low-grade papillary disease. Additional lab-based or office-based markers are needed to aid in the evaluation of these lesions. Recently, many such markers have been developed for the purpose of improving the cytologic diagnosis of bladder malignancies. In this review, we will first discuss conventional cytomorphologic analysis of urine cytology followed by a discussion of markers that have been developed in the past for detection and surveillance of urothelial carcinoma. We will focus on how these markers can be used in conjunction with urine cytology in daily practice.

Entities:  

Keywords:  Bladder cancer; tumor markers; urine cytology

Year:  2010        PMID: 20733951      PMCID: PMC2923865     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  206 in total

1.  Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.

Authors:  L Bubendorf; B Grilli; G Sauter; M J Mihatsch; T C Gasser; P Dalquen
Journal:  Am J Clin Pathol       Date:  2001-07       Impact factor: 2.493

2.  Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients.

Authors:  M Topsakal; T Karadeniz; M Anaç; S Dönmezer; A Besisik
Journal:  Eur Urol       Date:  2001-03       Impact factor: 20.096

3.  Comparison of urine cell characteristics by flow cytometry and cytology in patients suspected of having bladder cancer.

Authors:  Eric Barlandas-Rendón; Mathias M Müller; Ethel García-Latorre; Angelika Heinschink
Journal:  Clin Chem Lab Med       Date:  2002-08       Impact factor: 3.694

4.  Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

Authors:  Vinata B Lokeshwar; Tomonori Habuchi; H Barton Grossman; William M Murphy; Stefan H Hautmann; George P Hemstreet; Aldo V Bono; Robert H Getzenberg; Peter Goebell; Bernd J Schmitz-Dräger; Jack A Schalken; Yves Fradet; Michael Marberger; Edward Messing; Michael J Droller
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

5.  Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis.

Authors:  Stefan Tritschler; Sonja Scharf; Alexander Karl; Derya Tilki; Ruth Knuechel; Arndt Hartmann; Christian G Stief; Dirk Zaak
Journal:  Eur Urol       Date:  2006-08-15       Impact factor: 20.096

6.  Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.

Authors:  R Heicappell; M Schostak; M Müller; K Miller
Journal:  Scand J Clin Lab Invest       Date:  2000-07       Impact factor: 1.713

Review 7.  HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.

Authors:  V B Lokeshwar; N L Block
Journal:  Urol Clin North Am       Date:  2000-02       Impact factor: 2.241

8.  Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.

Authors:  L B Mora; S V Nicosia; J M Pow-Sang; N K Ku; J I Diaz; J Lockhart; A Einstein
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

9.  Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.

Authors:  Isabelle Renard; Steven Joniau; Ben van Cleynenbreugel; Catherine Collette; Christophe Naômé; Ilse Vlassenbroeck; Hubert Nicolas; Jean de Leval; Josef Straub; Wim Van Criekinge; Wissem Hamida; Majed Hellel; Alexandre Thomas; Laurence de Leval; Katja Bierau; David Waltregny
Journal:  Eur Urol       Date:  2009-08-05       Impact factor: 20.096

10.  Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.

Authors:  Gerhard Feil; Andreas Zumbrägel; Hans J Päulgen-Nelde; Jörg Hennenlotter; Sabine Maurer; Stefen Krause; Karl-Horst Bichler; Arnulf Stenzl
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

View more
  26 in total

1.  Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies.

Authors:  Latifa El Bali; Aurélie Diman; Alfred Bernard; Nancy H C Roosens; Sigrid C J De Keersmaecker
Journal:  J Biomol Tech       Date:  2014-12

Review 2.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

3.  Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Authors:  Beate Pesch; Dirk Taeger; Georg Johnen; Katarzyna Gawrych; Nadine Bonberg; Christian Schwentner; Harald Wellhäusser; Matthias Kluckert; Gabriele Leng; Michael Nasterlack; Yair Lotan; Arnulf Stenzl; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2013-10-16       Impact factor: 3.015

4.  Evaluation of Sienna Cancer Diagnostics hTERT Antibody on 500 Consecutive Urinary Tract Specimens.

Authors:  Derek B Allison; Rajni Sharma; Morgan L Cowan; Christopher J VandenBussche
Journal:  Acta Cytol       Date:  2018-06-06       Impact factor: 2.319

5.  Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.

Authors:  Chong Shen; Zeyu Sun; Deying Chen; Xiaoling Su; Jing Jiang; Gonghui Li; Biaoyang Lin; Jiajun Yan
Journal:  OMICS       Date:  2015-01

6.  Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.

Authors:  Zhenzhen Liang; Rui Xin; Yinghui Yu; Rui Wang; Chunpeng Wang; Xin Liu
Journal:  World J Urol       Date:  2018-04-02       Impact factor: 4.226

7.  Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer.

Authors:  Huihui Hu; Qian Meng; Ting Lei; Man Zhang
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

8.  Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.

Authors:  Maria Del Carmen Rodriguez Pena; Aline C Tregnago; Marie-Lisa Eich; Simeon Springer; Yuxuan Wang; Diana Taheri; Dilek Ertoy; Kazutoshi Fujita; Stephania M Bezerra; Isabela W Cunha; Maria Rosaria Raspollini; Lijia Yu; Trinity J Bivalacqua; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; George J Netto
Journal:  Virchows Arch       Date:  2017-06-08       Impact factor: 4.064

Review 9.  The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.

Authors:  Ilhan Karaoglu; Antoine G van der Heijden; J Alfred Witjes
Journal:  World J Urol       Date:  2013-10-29       Impact factor: 4.226

10.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.